Instructions for Tenoliof (Tenoxicam) lyophilisate for solution preparation
English product name Tenoliof
Tenoliof
Release Form Tenoliof
lyophilizate d/prescription r-ra d/v/v and b/m of introduction 20 mg: fl. 1 or 3 pcs. per set with solvent
Description lyophilisate for solution preparation:
Lyophilizate for preparation of solution for injection into/into/into/into/out - lyophilized powder or compacted mass from yellow to greenish-yellow; solvent - colorless transparent liquid.
1 fl
tenoxicam 20 mg
Auxiliary substances: mannitol - 66 mg, sodium disulpite - 2.1 mg, dehydrate edetate - 0.22 mg, tromethamol - 3.4 mg, sodium hydroxide solution 1M - up to pH 9.8±0.2.
Solvent composition (per 1 amp.): water d/i - 2 ml.
20 mg - bottles (1) with a distributor (amp). 2 ml-1 pcs.) - packages of cell contours (1) - packs of cardboard.
20 mg - bottles (3) with a distributor (amp). 2 ml-3 pcs.) - packages of cell contours (1) - packs of cardboard.
ATC codes
M01AC02 Tenoxicam
Active substance
tenoxicam
Pharmaco-therapeutic group Tenoliof
NSAIDs
Pharmacological effect Tenoxicam
NSAIDs of the Oxicam class. It has a powerful analgesic and anti-inflammatory effect, the antipyretic effect is less pronounced. The mechanism of action is based on the suppression of the activity of the isoenzymes COX-1 and COX-2, as a result of which prostaglandin synthesis in the site of inflammation, as well as in other tissues of the body, is reduced. In addition, tenoxicam reduces the accumulation of leukocytes in the site of inflammation. A distinctive feature of tenoxicam is its long duration of action. Its T1/2 is 72 h.
Testimony Tenoliof
Symptomatic treatment as an anti-inflammatory and analgesic agent: rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, articular syndrome in aggravation of gout, bursitis, tendovaginitis; pain syndrome of mild and moderate intensity (artralgia, myalgia, neuralgia, migraine, toothache and headache, algodismenorrhea); pain in injuries, burns. Inflammatory and degenerative diseases of the musculoskeletal system, accompanied by pain syndrome, such as sciatica, lumbago, epicondylitis.
Method of use, course and dosage Tenoxicam
Used inwards, in/in, in/m. The recommended dose is twenty mg once a day. The duration of treatment is 7-14 days.
- Nosology Tenoxicam (ICD codes)
- G43
- Migraine
- K08.8
- Other refined changes of teeth and their support apparatus (including toothache)
- M05
- Seropositive rheumatoid arthritis
- M10
- Podagra
- M13.9
- Arthritis unspecified
- M15
- Polyarthrosis
- M19.9
- Arthrosis unspecified
- M25.5
- Joint pain
- M42
- Spinal osteochondrosis
- M45
- Ankylosing spondylitis
- M47
- Spondylosis
- M54.1
- Radikulopathy
- M54.3
- Ishias
- M54.4
- Lumbago with Sciatica
- M65
- Synovitis and tenosinovites
- M70
- Soft tissue diseases related to load, overload and pressure
- M71
- Other bursopathy
- M77
- Other Entesopathy (epicondylitis)
- M79.1
- Mialgia
- M79.2
- Neuralgia and Neuritis Unspecified
- N94.4
- Primary Dysmenorrhea
- N94.5
- Secondary dysmenorrhea
- R51
- Headache
- R52.0
- Acute pain
- R52.2
- Other persistent pain (chronic)
- T14.0
- Superficial injury of an unspecified area of the body (including abrasion, bruising, bruising, hematoma, bite of a non-venomous insect)
- T14.3
- Dislocation, stretching and overtension of the capsule-bonding apparatus of the unspecified body region joint
- T14.9
- Injury unspecified
- T30
- Thermal and chemical burns of unspecified location
